TherapeuticsMD (TXMD) Reports Q1 Loss of $0.24/sh

TherapeuticsMD (NASDAQ: TXMD) reported Q1 EPS of ($0.24), versus ($2.08) reported last year. Revenue for the quarter came in at $400 thousand, versus $700 thousand reported last year.

For earnings history and earnings-related data on TherapeuticsMD (TXMD) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• The free USDA tool that tracks egg prices at $0.62/dozen before your data vendor does
• 374Water Inc (SCWO) Misses Q2 EPS by 15c